. 2019 Dec 27;34(4):e23146. doi: 10.1002/jcla.23146

Table 3.

Stratification analysis of risk genotypes with endometrial cancer susceptibility

Variables	rs591291 (cases/controls)		AOR (95% CI)a	P a	rs664589 (cases/controls)		AOR (95% CI)a	P a	rs4102217 (cases/controls)		AOR (95% CI) a	P a
Variables	AA	AG/GG	AOR (95% CI)a	P a	CG/CC	GG	AOR (95% CI)a	P a	AA/AC	CC	AOR (95% CI) a	P a
Surgery history
Yes	45/77	8/17	0.81 (0.32‐2.02)	.644	50/92	3/2	2.76 (0.45‐17.06)	.275	52/92	1/2	0.89 (0.08‐9.99)	.921
No	168/301	28/49	1.02 (0.62‐1.69)	.927	190/350	6/2	5.53 (1.11‐27.64)	.037	192/345	4/6	1.20 (0.33‐4.30)	.782
Menopause
Yes	141/228	24/37	1.05 (0.60‐1.83)	.866	158/2657	7/0	–	–	164/258	1/6	0.26 (0.03‐2.20)	.217
No	72/150	12/29	0.86 (0.42‐1.79)	.690	82/177	2/4	1.08 (0.19‐6.02)	.929	80/179	4/2	4.48 (0.80‐24.93)	.087
Delivery
=0	5/4	1/0	–	–	6/4	0/0	–	–	6/4	0/0	–	–
=1	57/5	85/13	0.57 (0.19‐1.70)	.315	60/97	2/1	3.23 (0.29‐36.43)	.342	62/97	0/1	–	–
≥2	151/289	30/53	1.08 (0.66‐1.77)	.748	174/341	7/3	4.57 (1.17‐17.90)	.029	176/336	5/7	1.36 (0.43‐4.36)	.601
BMI
<18.5	18/26	3/1	4.33 (40.42‐45.06)	.220	21/27	0/0	–	–	21/27	0/0	–	–
18.5 ≤ BMI ≤ 24.9	96/204	17/43	0.84 (0.46‐1.55)	.677	111/246	2/2	2.22 (0.31‐15.93)	.429	112/241	1/6	0.36 (0.04‐3.01)	.345
25.0 ≤ BMI ≤ 29.9	76/123	13/19	1.11 (0.52‐2.37)	.793	83/141	6/2	5.10 (1.01‐25.83)	.049	86/141	3/2	2.46 (0.40‐15.01)	.330
30.0 ≤ BMI ≤ 40	19/16	3/3	0.84 (0.15‐4.76)	.846	21/19	1/0			21/19	1/0	–	–
FIGO stage
I	190/378	23/378	0.90 (0.56‐1.45)	.675	211/422	8/4	4.00 (1.18‐13.61)	.027	214/437	5/8	1.40 (0.45‐4.35)	.566
II	29/66	7/66	1.82 (0.72‐4.57)	.203	29/422	1/4	15.4 (1.06‐224.76)	.046	30/437	0/8	–	–

Abbreviations: AOR, adjusted odds ratio; CI, confidence interval.

Adjusted for surgery history, menopause, delivery, and BMI.

The results were in bold, if the 95% CI excluded 1 or P < .05.